SECsense Logo

Insmed Incorporated 8-K Report: Key Developments as of February 18, 2025

$INSM
Form 8-K
Filed on: 2025-02-20
Source
Insmed Incorporated 8-K Report: Key Developments as of February 18, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Filing Type: The document is an 8-K filing, which is typically used to report major events that shareholders should know about.
  2. Company Information:
  • Company Name: Insmed Incorporated
  • State of Incorporation: Virginia (VA)
  • CIK Number: 0001104506
  • SEC File Number: 000-30739
  • EIN: 54-1972729
  • Address: 700 US Highway 202/206, Bridgewater, NJ 08807
  • Contact Number: 908-977-9900
  1. Stock Information:
  • Common Stock Par Value: $0.01 per share
  • Ticker Symbol: INSM
  • Exchange: NASDAQ
  1. Reporting Period:
  • Report Date: February 18, 2025
  • Period Covered: The report covers a single day, February 18, 2025.
  1. XBRL Information: The report is structured in XBRL (eXtensible Business Reporting Language), which is a standardized format for financial reporting that allows for easier data extraction and analysis.

Overall, this section indicates that Insmed Incorporated has submitted an 8-K report, which could denote a significant event or development as of February 18, 2025. The information is critical for investors and analysts tracking the company's performance and corporate governance.